客观: 选择 carcinoembryonic 抗原(CEA ) 的特定的恰当的 amer,为癌症的最吸引人的分子之一指向治疗和成像。方法:在 vitro 选择的七个回合对净化的 CEA 蛋白质被执行。调停 Ligand 的目标纯化和 Co-immunoprecipitation 被采用验证恰当的 amer 的特定的绑定到净化并且本国的蛋白质独立。能绑两个的 ResultsrThe CEA 特定的恰当的 amer 净化,有高特性的本国的蛋白质被获得。结论: 这是 CEA 特定的 apatmer 被生产的第一次。在这的结果学习以后为 CEA-aptamer 的进一步的调查和申请提供初步的证据。
Objective:To select the specific aptamer of carcinoembryonic antigen (CEA), one of the most attractive molecule for cancer target therapy and imaging. Methods: Seven rounds in vitro selection were performed against the purified CEA protein. Ligand-mediated target purification and Co-immunoprecipitation were adopted to verify the specific binding of the aptamer to the purified and native protein separately. Results:The CEA-specific aptamer which can bind both the purified and native protein with the high specificity was obtained. Conclusion:This is the first time the CEA specific apatmer was produced. The results in this study provides the preliminary evidence for further investigation and application of CEA-aptamer in the future.